Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

References for PMC Articles for PubMed (Select 14745321)

1.

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

EDMONDSON HA, STEINER PE.

Cancer. 1954 May;7(3):462-503. No abstract available.

PMID:
13160935
2.

Living-donor liver transplantation for hepatocellular carcinoma.

Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, Kozaki K, Tanaka K.

Transplantation. 2003 Feb 15;75(3 Suppl):S37-40.

PMID:
12589138
3.

Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation.

Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, Yamaoka Y, Regimbeau JM, Belghiti J, Curley SA, Ellis LM, Vauthey JN.

J Gastrointest Surg. 2002 Mar-Apr;6(2):224-32; discussion 232.

PMID:
11992808
4.

Current status of liver transplantation for treatment of hepatocellular carcinoma.

Frilling A, Malago M, Broelsch CE.

Dig Dis. 2001;19(4):333-7. Review.

PMID:
11935093
5.

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters.

Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, Miller CM, Schwartz ME.

Ann Surg. 2002 Apr;235(4):533-9.

6.

Simplified staging for hepatocellular carcinoma.

Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney DM.

J Clin Oncol. 2002 Mar 15;20(6):1527-36.

PMID:
11896101
7.

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Bruix J, Llovet JM.

Hepatology. 2002 Mar;35(3):519-24. Review. No abstract available.

PMID:
11870363
8.

Liver transplantation for malignant diseases: selection and pattern of recurrence.

Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I.

World J Surg. 2002 Feb;26(2):257-63. Epub 2001 Dec 11.

PMID:
11865357
9.

Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index.

Lauwers GY, Terris B, Balis UJ, Batts KP, Regimbeau JM, Chang Y, Graeme-Cook F, Yamabe H, Ikai I, Cleary KR, Fujita S, Flejou JF, Zukerberg LR, Nagorney DM, Belghiti J, Yamaoka Y, Vauthey JN; International Cooperative Study Group on Hepatocellular Carcinoma.

Am J Surg Pathol. 2002 Jan;26(1):25-34.

PMID:
11756766
10.

Close correlation of p53 mutation to microvascular invasion in hepatocellular carcinoma.

Park NH, Chung YH, Youn KH, Song BC, Yang SH, Kim JA, Lee HC, Yu E, Lee YS, Lee SG, Kim KW, Suh DJ.

J Clin Gastroenterol. 2001 Nov-Dec;33(5):397-401.

PMID:
11606857
11.

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J; EASL Panel of Experts on HCC.

J Hepatol. 2001 Sep;35(3):421-30. No abstract available.

PMID:
11592607
12.

Liver transplantation for early-detected, multifocal hepatocellular carcinoma.

Salizzoni M, Zamboni F, Lupo F, Franchello A, David E, Rizzetto M.

Br J Surg. 2001 Sep;88(9):1194-5. No abstract available.

PMID:
11531866
13.

High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.

Donato MF, Arosio E, Del Ninno E, Ronchi G, Lampertico P, Morabito A, Balestrieri MR, Colombo M.

Hepatology. 2001 Sep;34(3):523-8.

PMID:
11526538
14.

Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications.

Kirimlioglu H, Dvorchick I, Ruppert K, Finkelstein S, Marsh JW, Iwatsuki S, Bonham A, Carr B, Nalesnik M, Michalopoulos G, Starzl T, Fung J, Demetris A.

Hepatology. 2001 Sep;34(3):502-10.

15.

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP.

Hepatology. 2001 Jun;33(6):1394-403.

PMID:
11391528
16.

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma.

Ito Y, Takeda T, Sakon M, Tsujimoto M, Higashiyama S, Noda K, Miyoshi E, Monden M, Matsuura N.

Br J Cancer. 2001 May 18;84(10):1377-83.

17.

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, Settmacher U, Neuhaus P.

Hepatology. 2001 May;33(5):1080-6.

PMID:
11343235
18.

Liver transplantation for hepatocellular carcinoma.

Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ.

Ann Surg. 2001 May;233(5):652-9.

19.

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study.

Poon RT, Ng IO, Lau C, Zhu LX, Yu WC, Lo CM, Fan ST, Wong J.

Ann Surg. 2001 Feb;233(2):227-35.

20.

Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.

Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, Nery JR, Burke GW, Schiff ER, Miller J, Tzakis AG.

Arch Surg. 2001 Jan;136(1):25-30; discussion 31.

PMID:
11146770
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk